W
WAVEMAN · COMPANY
EOCN · Galmed Pharmaceuticals Ltd.
> Ask across nine datasets ⌘K
LIVE
TEAM+7.27% 13F +439META+2.71% 13F +2,701RCG+0.33% CLUSTERUTHR+1.12% 13F +425CRWV-6.75% 13F +692CRM+4.73% 13F +1,021CVNA+2.47% 13F +797DELL-5.82% 13F +1,205TPL-1.04% 13F +443NET+7.77% 13F +712MSTR+4.56% 13F +525CRWD+13.85% 13F +1,383ANET+2.68% 13F +1,324COIN+9.24% 13F +474TEAM+7.27% 13F +439META+2.71% 13F +2,701RCG+0.33% CLUSTERUTHR+1.12% 13F +425CRWV-6.75% 13F +692CRM+4.73% 13F +1,021CVNA+2.47% 13F +797DELL-5.82% 13F +1,205TPL-1.04% 13F +443NET+7.77% 13F +712MSTR+4.56% 13F +525CRWD+13.85% 13F +1,383ANET+2.68% 13F +1,324COIN+9.24% 13F +474
← ALL COMPANIES

EOCN

Galmed Pharmaceuticals Ltd.
PHARMA & BIOTECH · PHARMACEUTICAL PREPARATIONS · CIK 0001595353
SEC FILINGS☆ WATCH
INSIDER NET · 180D
-
open-market buys minus sells, Form 4 codes P and S
INSIDER BUYERS · 180D
0
CONGRESS BUYERS · 1Y
0
FUNDS ADDED · QTR
4
13F, latest reported quarter
REVENUE GROWTH
-
XBRL, annual
NET MARGIN
-
SEVEN FACTS, RANKED AGAINST THE SECTOR · RANK IS NOT A FORECAST
INSIDERS
no Form 4 purchases or sales on file
CONGRESS
no member of Congress has reported trading it
FUNDS
4 funds added or opened last quarter
below 97% of Pharma & Biotech
REVENUE
no revenue reported in any filing
MARGIN
no margin: this company reports no revenue to divide by
BUYBACKS
no share repurchases reported
SHORT
no short interest reported
Live price
Daily candles from TradingView, on their licence , no filings are marked on this one
WHY THIS NAME IS ON THE DESK
The complete filing record, in one place.
The record shows 4 funds added last quarter. Every figure is a federal filing, dated the day it became public.
Backtest this pattern Open the screener
Same sector, ranked by filing activity
Sector from the SEC's own SIC classification
UTHRCPIXMRNAREGNLLYALNYELFMDGLCITRDNAVRTXNUVL
Insider transactions
Form 4 purchases and sales (codes P and S), grants, option exercises and preferred conversions excluded

No insider purchases or sales are on record for Galmed Pharmaceuticals Ltd. in the period covered. Source: SEC Form 4 filings, as of 2026-09-16.

INSIDER
FILED
SHARES
VALUE

no insider purchases or sales on record

0 TRANSACTIONS ON RECORD

Showing the most recent few. Create a free account to see the full history, the screener and CSV export, the cross-source screener and CSV export. We store only your email address, and there is no password to create.

Institutional holders
13F · holdings as of the latest quarter funds have reported
CITADEL ADVISORS LLC
86,851.0 sh
$48.3K
XTX Topco Ltd
15,015.0 sh
$8.4K
TWO SIGMA SECURITIES, LLC
11,012.0 sh
$6.1K
SBI Securities Co., Ltd.
66.0 sh
$37
MORGAN STANLEY
56.0 sh
$31
SCHEDULE 13D/G
No 5%+ ownership filings
Nobody has crossed 5% with a filing obligation. Absence is a fact here, not missing data.
FORM 144
No planned-sale notices
No insider has notified an intent to sell. This is the panel to watch after a run-up.